We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTO:NASDAQUTime Limited Analysis

Data as of 2026-06-22 - not real-time

$5.27

Latest Price

8/10Risk

Risk Level: High

Executive Summary

UTime Limited (WTO) is currently trading well beneath its short‑term moving averages, with the 20‑day SMA and 50‑day SMA both positioned above the market price, indicating a pronounced bearish bias. The 14‑day RSI is deep in oversold territory, while the MACD line sits below its signal line, producing a bearish histogram. A negative beta suggests the stock moves opposite to broader market trends, and the 30‑day volatility is exceptionally high, reflecting erratic price swings. Despite the market’s “Extreme Greed” sentiment, the technical picture remains fragile, compounded by an increasing volume trend that may be driven more by speculative trading than fundamental support.
Fundamentally, the company reports negative earnings, a high debt‑to‑equity ratio, and a substantial max drawdown, all of which undermine confidence. However, a discounted cash‑flow model points to a valuation far above the current price, and the pending reverse stock split, along with ongoing due‑diligence on a potential transaction with Feixiaohao, could serve as catalysts if the deal materialises. Investors must weigh the stark contrast between the deep discount and the company’s deteriorating financial health when forming a view on WTO.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (RSI, MACD, SMA positioning)
  • Extreme price volatility and negative beta
  • Uncertainty surrounding the reverse stock split

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from the Feixiaohao transaction
  • Significant valuation gap between DCF fair value and market price
  • Continued financial distress and high debt levels

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Deep discount to intrinsic value offering speculative upside
  • Possible strategic turnaround if partnership proceeds
  • Long‑term exposure to growth in the consumer electronics market

Key Metrics & Analysis

Financial Health

Revenue Growth-28.10%
Profit Margin-251.46%
ROE-253.66%
ROA-56.82%
Debt/Equity182.80
P/B Ratio0.2
Op. Cash Flow$-11513000
Free Cash Flow$187.5M
Industry P/E38.1

Technical Analysis

TrendBearish
RSI28.5
Support$5.16
Resistance$23.50
MA 20$9.62
MA 50$14.14
MA 200$944.63
MACDBearish
VolumeIncreasing
Fear & Greed Index89.96

Valuation

Fair Value$1,361.68
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.86
Volatility179.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.